LENNAR BEGINS SALES AT STONEGATE PRESERVE, NEW AMENITY-RICH MASTER-PLANNED COMMUNITYIN PALMETTO, FLORIDA
Lennar is offering fifteen floorplans across three unique home collections at
The Manors encompasses three brand-new floorplans: Vail, Stowe and Greylock. Lennar's popular Next Gen® multi-generational "Home Within a Home" floorplan, the Liberation, is available within The Executives collection. With a dedicated entrance, kitchenette with refrigerator and microwave, living space, bedroom and bath, laundry room with washer/dryer hook-ups, and lanai, Next Gen® models are perfect for an aging parent or even a grown child coming back to the nest.
"
Every home offers Lennar's signature Everything's Included® program, where the homebuilder's most popular options and upgrades are built into the base price of the home. At
Residents at
The community is located just off of
Lennar is now actively selling homes at
Four professionally designed model homes are now under construction at
For more information on
About Lennar Corporation
Lennar Corporation, founded in 1954, is one of the nation's leading builders of quality homes for all generations. Lennar builds affordable, move-up and active adult homes primarily under the Lennar brand name. Lennar's Financial Services segment provides mortgage financing, title and closing services primarily for buyers of Lennar's homes and, through LMF Commercial, originates mortgage loans secured primarily by commercial real estate properties throughout the
###
Contact: Danielle Tocco
Vice President Communications
Lennar Corporation
[email protected]
Direct Line: 949.789.1633
View original content to download multimedia:https://www.prnewswire.com/news-releases/lennar-begins-sales-at-stonegate-preserve-new-amenity-rich-master-planned-communityin-palmetto-florida-302052402.html
SOURCE Lennar Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GO FURTHER: NATIONAL GEOGRAPHIC-LINDBLAD EXPEDITIONS UNVEILS 2028-29 DEPLOYMENT
- AQUAPASS Completes Enrollment in REFORM-HF Pivotal Trial, Results to Be Presented at Major Heart Failure Conference This Fall
- THE LUSTGARTEN FOUNDATION AND BREAK THROUGH CANCER ANNOUNCE NEW CLINICAL TRIAL EVALUATING KRAS-TARGETED IMMUNOTHERAPY STRATEGY FOR PANCREATIC CANCER
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share